Original articlePrinciples of nonexperimental assessment of excess risk, with special reference to adverse drug reactions☆
References (18)
- et al.
Analgesics, agranulocytosis and aplastic anemia
Lancet
(1987) - et al.
Safety of dipyrone. Letter to the Editor
Lancet
(1986) - et al.
Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia Study
J Chron Dis
(1987) - et al.
Postmarketing studies of drug efficacy: how?
Am J Med
(1984) The “case-control” study: valid selection of subjects
J Chron Dis
(1985)Striving to deconfound the fundamentals of epidemiologic study design
J Clin Epidemiol
(1988)Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics
JAMA
(1986)Dipyrone hearing by the German Drug Authority
Lancet
(1986)Analgesics, agranulocytosis, and aplastic anemia: a major case-control study
Lancet
(1986)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
This work was supported by Hoechst AG, Frankfurt, Federal Republic of Germany, and by the Institute for Research in Extramural Medicine, Free University, Amsterdam.
Copyright © 1989 Published by Elsevier Inc.